Tickle Therapy - Fae DCay

Description:

Evaluating Stress Decompression Efficacy in the Fettishlabs Tickle Therapy Device – Case Study: Specimen Fae DCay

Abstract

This controlled experimental study investigates the physiological and psychological impact of sensory stimulation on stress levels using the proprietary Fettishlabs Tickle Therapy Device. The subject, Specimen Fae DCay, experienced sensory input to assess whether such stimulation induces stress reduction or change. Baseline and post-intervention stress markers were recorded. Results indicate a response: initial stress elevation followed by a shift toward calm, suggesting potential for regulated tickle therapy as a novel biofeedback-based decompression modality.

Introduction

Chronic stress remains a pervasive public health concern. Fettishlabs has pioneered research into sensory dominance therapy, exploring neurological pathways for emotional regulation. This study focuses on tactile intervention, wherein sensory input is administered to trigger a neurochemical cascade.

The FTTD employs calibrated modules to maximize foot sensitivity. This case study evaluates the device’s potential as a clinical tool for stress management within a sensory-focused framework.

Methodology

Subject Profile

• Designation: Fae DCay
• Age: 28
• Gender: Female
• Psych Profile: High sensory sensitivity, history of anxiety disorder (GAD), voluntary participant in sensory research
• Consent Status: Full, documented

Restraint Protocol (Standard FTTD-7)

Fae was secured in the Therapy Chair using the following constraints:

• Lower Limbs:
• Thigh belts
• Knee and shin straps
• Padded Stocks: feet encased
• Toes bound in full flexion, exposing all phalanges and webbing
• Upper Body:
• Straitjacket with crossed-arm configuration
• Chest restraint
• Shoulder immobilizers
• Headrest

Stress Measurement

• Pre-Treatment Baseline:
• Salivary cortisol
• HRV
• Self-Reported Anxiety Scale – Revised (SAS-R)
• During Stimulation:
• Continuous ECG monitoring
• Vocal Distress Index (VDX)
• Sweat response sensors
• Real-time facial EMG
• Post-Treatment:
• Repeat cortisol and HRV
• SAS-R post-debrief
• Open-ended emotional state interview

Stimulation Protocol

• Phase 1: Period of silence and immobilization
• Phase 2: Application of escalating stimuli:
• Fingers
• Soft bristles
• Vibrating implements
• Intense Terrorizer and Shriekers applied
• Manual simulation
• Phase 3: Cool-down
• Phase 4: Post-Stress Assessment

Results

| Metric | Pre-Treatment | Peak During Stimulation | Post-Treatment | |--------|---------------|--------------------------|----------------| | Heart Rate (bpm) | 76 | 138 | 68 | | HRV (ms²) | 62 | 18 | 79 | | Cortisol (μg/dL) | 0.45 | 0.61 | 0.29 | | VDX Score (0–10) | 1.2 | 8.9 | 2.1 | | SAS-R Score | 4.3 | 7.6 | 2.4 |

Key Observations

• Initial Stress Spike: Confirmed across all metrics during the beginning of stimulation.
• Neurological Shift: Vocalizations transitioned from laughter to rhythmic gasping, followed by whispered submission cues.
• Parasympathetic Takeover: HRV and cortisol dropped below baseline during recovery, indicating deep relaxation.

Discussion

The data suggests that sensory input under restraint triggers a stress inversion effect (SIE), where prolonged stimulation leads to neurological surrender and subsequent calm.

Post treatment, Fae reported: “It started like panic… but then I just… let go. Like falling into warm water. My feet were on fire, but my mind was blank. I’ve never felt so… light after.”

This supports the hypothesis that controlled tickle stimulation may serve as a viable stress decompression technique for select individuals, particularly those responsive to sensory input and consensual helplessness.

Conclusion

The Fettishlabs Tickle Therapy Device demonstrates significant potential in inducing rapid stress reduction through sensory input. While not suitable for all populations, this modality offers a novel, non-pharmacological intervention for anxiety regulation.

Further studies with larger N-values and diverse neurotypes are recommended. Pending ethical review, Fettishlabs Stress Decompression Therapy (FSDT) is projected for limited release.